Table 2 Barnes maze assessment. Control mice (C), diabetic mice (D), mice subjected to permanent middle cerebral artery occlusion (pMCAo) and diabetic mice subjected to permanent middle cerebral artery occlusion (pMCAo + D)
From: Increased serum QUIN/KYNA is a reliable biomarker of post-stroke cognitive decline
Days | C (n = 10) | D (n = 9) | pMCAo (n = 10) | pMCAo + D (n = 10) |
|---|---|---|---|---|
1st | 162.9 ± 51.5 | 173.4 ± 55.7 | 148.2 ± 25.39 | 189.4 ± 37.7 |
2nd | 81.1 ± 31.5 | 102.5 ± 42.5 | 71.3 ± 40.65 | 113.5 ± 35.8 |
3rd | 47.9 ± 18.1 | 41.7 ± 28.8 | 64.5 ± 20.10 | 83.1 ± 28.7 |
4th | 41.4 ± 23.5 | 32.9 ± 11.4 | 33.9 ± 15.15 | 62.1 ± 53.7 |
7th | 40.7 ± 21.8 | 28.0 ± 10.7 | 28.9 ± 12.6 | 87.6 ± 46.2 |
8th | 60.2 ± 21.8 | 82.9 ± 47.0 | 61.5 ± 29.1 | 113.2 ± 32.6 |
9th | 36.7 ± 15.2 | 34.1 ± 15.2 | 31.0 ± 38.6 | 84.1 ± 67.0 |
10th | 44.6 ± 26.6 | 39.3 ± 13.9 | 38.3 ± 25.4 | 86.8 ± 69.7 |
11th | 31.3 ± 16.6 | 36.9 ± 13.6 | 29.9 ± 9.5 | 77.0 ± 63.4 |